DIA 2013 49th Annual Meeting
Click here to go to the previous page
Innovations in Proactive Quality Management: Best Practices and Variability in Approaches to Proactive Quality Management
Track
:
Track 11: Innovative Approaches to Ensuring Compliance with Good Clinical Practice (GCP) and Quality Assurance (QA)
Program Code:
378
Date:
Wednesday, June 26, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
156AB
CHAIR
:
Steven B. Whittaker, (SCHNON), The Avoca Group, United States
SPEAKER
(S):
Jennifer G. Marsh, (SPKNON), Senior Director, Global Medical Quality, Eli Lilly and Company, United States
Coleen M. Glessner, (SPKNON), Vice President, Clinical Trial Processes and Quality, Pfizer Inc, United States
Fergus Sweeney, PhD (SPKAGY), Head of Sector, Compliance and Inspection, European Medicines Agency, European Union, United Kingdom Cassandra Kennedy, (SCHNON), Senior Vice President, Global Quality Assurance, Quintiles Inc., United States Ann Meeker-O'Connell, MS (SPKAGY), Senior Director, QA Clinical Strategy Team Lead, Janssen Pharmaceutica Inc., United States
Description
This forum will explore industry best practices and the variability in industry approaches to quality management. Data from the 2012 Quality Consortium Assessment research will be shared. A panel of industry experts and representatives from the FDA and EMA will provide their perspectives.
This session is a part of:
This session is a part of: